The FDA lacked or had inadequate policies in place to identify risks to the infant formula supply chain when it received complaints about production at a plant in Sturgis, Michigan, said an inspector general’s report on Thursday. Months passed before the FDA warned consumers in February 2022 not to use some of the products made… » Read More